Thalidomide and beyond: some recommendations regarding public policies toward the ethical drug industry.
D003132:Commerce; D004345:Drug Industry; D004335:Drug and Narcotic Control; D004994:Ethics, Pharmacy; D005252:Fees, Pharmaceutical; D006801:Humans; D007885:Legislation, Pharmacy; D008004:Licensure; D004364:Pharmaceutical Preparations / Q000592:standards; D011057:Politics; D012109:Research Support as Topic; D013792:Thalidomide / Q000009:adverse effects; D013810:Therapeutic Equivalency; D014481:United States; D014486:United States Food and Drug Administration
D004364:Pharmaceutical Preparations; D013792:Thalidomide